Patient Medication Information: uses, side effects, how to take - Sogroya
What SOGROYA® is used for:
- SOGROYA® is used for the long-term treatment of children and adolescents who are not growing because of low growth hormone levels.
- SOGROYA® also replaces the growth hormone in adults with growth hormone deficiency.
How SOGROYA® works:
SOGROYA® contains the active substance ‘somapacitan’.
- Somapacitan is a long-acting version of the natural growth hormone produced by the body with a single amino acid substitution.
- Somapacitan is made by ‘recombinant DNA technology’ meaning from cells that have received a gene (DNA) that makes them produce growth hormone. In SOGROYA®, a small side-chain has been attached to the growth hormone which links SOGROYA® to the protein (albumin) naturally found in the blood to slow down its removal from the body allowing the medicines to be given less often.
The ingredients in SOGROYA® are:
Medicinal ingredients: somapacitan
Non-medicinal ingredients: histidine, hydrochloric acid (as needed), mannitol, phenol, poloxamer 188, sodium hydroxide (as needed) and water for injection
SOGROYA® comes in the following dosage forms:
- 15 mg / 1.5 mL pen with a rubine red pen cap and dose button
Do not use SOGROYA® if:
- If you or the child in your care are allergic to ‘somapacitan’ or ‘phenol’ or any of the other ingredients of SOGROYA® (see The ingredients in SOGROYA® are:).
SOGROYA® is available as a pre-filled disposable pen in 3 colour coded strengths:
- 5 mg / 1.5 mL pen with a teal pen cap and dose button
- 10 mg / 1.5 mL pen with a yellow pen cap and dose button
- If you or the child in your care have a benign or malignant tumour which is growing. You must have finished your anti-tumour treatment before you start your SOGROYA® treatment. SOGROYA® must be discontinued if the tumour grows.
- (Adults only) If you have had open heart surgery or abdominal surgery.
- (Adults only) If you have serious accidental injury, severe breathing problems.
- (Children only) If your bones have already finished growing (this is called closure of the growth plates).
- (Children only) If you have Prader-Willi syndrome and are severely obese or have breathing problems, including sleep apnea.
To help avoid side effects and ensure proper use, talk to your healthcare professional before you take SOGROYA®. Talk about any health conditions or problems you may have, including if you or the child in your care:
- have ever had any kind of cancer or another kind of tumour.
- have high blood sugar (hyperglycemia) as your blood sugar may need to be checked regularly and the dose of your diabetes medicines may need to be adjusted.
- have a replacement therapy with glucocorticoids, because you have been told your body does not produce enough (adrenocortical insufficiency). You should consult your doctor regularly, as you may need adjustment of your glucocorticoid dose.
- have severe headaches, eyesight problems, nausea, or vomiting as these could be symptoms of increased pressure in the brain (benign intracranial hypertension) as your treatment may need to be stopped.
- have thyroid problems, your thyroid hormones need to be checked regularly and your dose of thyroid hormone may need to be adjusted.
- are a female taking oral contraception or hormonal replacement therapy with estrogen, your dose of SOGROYA® may need to be higher. If you stop using oral estrogen, your dose of SOGROYA® may need to be reduced. Your doctor may recommend you to change the route of estrogen administration (e.g. transdermal, vaginal)
are pregnant or plan to become pregnant. It is not known if SOGROYA® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant.
- are breastfeeding or plan to breastfeed. It is not known if SOGROYA® passes into your breast milk. You and your healthcare provider should decide if you will take SOGROYA® while you breastfeed.
- have scoliosis. Growth hormone treatment increases growth rate, and progression of pre-existing scoliosis can occur.
- (children only) have hip or knee pain, or begin to limp while on treatment.
- have changes in skin colour or in the appearance of birthmarks or moles on the skin.
- have persistent hip or knee pain when walking, or start to limp during growth hormone treatment. This could be symptoms of a condition (slipped capital femoral epiphysis) that affects the thighbone (femur) where it inserts into the hip. This condition occurs with greater frequency in fast growing children and children with endocrine disorders, including growth hormone deficiency. Talk to the doctor about persistent pain in any joint.
- Symptoms such as persistent hip and knee pain could also be caused by loss of bone tissue due to insufficient blood supply (osteonecrosis), which has been reported in patients treated with other growth hormone products. Talk to your doctor about persistent pain in any joint.
Other warnings you should know about:
Thickening of skin
If you inject SOGROYA® at the same site for a long period, thickened skin may appear where you inject your medicine. Change the place of injection on your body from one week to the next.
Antibodies
Antibodies against somapacitan may occur as it happens with other growth hormone treatments.
Tell your healthcare professional about all the medicines you or the child in your care take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
The following may interact with SOGROYA®:
- Glucocorticoids such as hydrocortisone, dexamethasone and prednisolone
- Estrogen as part of oral contraception or hormonal replacement therapy with estrogen
- Male sex hormones (androgen medicines) such as testosterone
- Gonadotropin medicines (gonad stimulating hormone) which stimulate the production of sex hormones
- Insulin or other diabetes medicines
- Thyroid hormone medicines such as thyroxine and levothyroxine
- Anticonvulsants medicines – such as carbamazepine and diazepam
- Cyclosporine (immunosuppressive) – a medicine to suppress your immune system
How to take SOGROYA®:
Always use this medicine exactly as your healthcare professional has told you. Check with your healthcare professional if you are not sure.
SOGROYA® is given as an injection under the skin (subcutaneous injection). Do not inject it into a vein or muscle. Before you use the pen for the first time, your doctor or nurse will show you how to use it.
The best places to give the injection are:
- the front of your thighs
- the front of your waist (abdomen)
- the buttocks
- the upper arms (children only)
Change the place on your body where you inject into every week.
For detailed instructions on how to inject SOGROYA®, please see Instructions for Use.
When to use SOGROYA®
- You or the child in your care should use SOGROYA® once a week on the same day each week if possible.
- You can give yourself the injection at any time of the day.
If you or the child in your care are changing from another weekly growth hormone therapy to SOGROYA®, you are advised to continue your usual once weekly dosing schedule.
If you or the child in your care are changing from daily growth hormone therapy to SOGROYA® choose the preferred day for the weekly dose and stop final dose of daily treatment the day before (or at least 8 hours before) taking the first dose of SOGROYA®.
Changing from another type or brand of growth hormone should be done by your healthcare professional.
On occasions when administration at the scheduled dosing day is not possible, you can take SOGROYA® up to 2 days before or 3 days after your scheduled dosing day. The next dose you can take as usual the following week.
If necessary, you can change the day of your weekly injection of SOGROYA® as long as it has been at least 4 days since your last injection of it. After selecting a new dosing day, continue with once a week dosing.
How long you will need treatment for
You may need SOGROYA® for as long as your body does not produce enough growth hormone
- If you or the child in your care are taking SOGROYA® for growth failure you will continue using SOGROYA® until you stop growing.
- If you or the child in your care still lack growth hormone after you stop growing, you may need to continue using SOGROYA® into adulthood.
- Do not stop using SOGROYA® without discussing this with your healthcare professional first.
Usual dose:
Children and adolescents
The dose for children and adolescents depends on their body weight. The recommended dose of SOGROYA® is 0.16 mg per kg body weight given once a week. Your child’s dose may be lowered from the recommended dose according to blood test results, as necessary.
Adults
The usual starting dose is 1.5 mg once a week if you get growth hormone treatment for the first time and if you are already in treatment with daily growth hormone (somatropin medicine). If you are a woman taking oral estrogen (contraception or hormonal replacement therapy) you may need a higher dose of SOGROYA®. If you are above 60 years, you may need a lower dose. See Table 1 below.
Table 1: Starting dose recommendation
| Adult growth hormone deficiency | Recommended starting dose |
|---|---|
| You are ≥18 to <60 years | 1.5 mg/week |
| You are a woman on oral estrogen therapy regardless of age | 2 mg/week |
| You are 60 years or above | 1 mg/week |
Your doctor may increase or decrease your dose step by step and regularly until you are on the right dose based on your individual needs and your experience of side effects.
- Do not take more than a maximum of 8 mg once a week.
- Do not change your dose unless your doctor has told you to.
After you have reached your right dose, your doctor will evaluate your treatment every 6 to 12 months. You may need to have your body mass index checked and blood samples taken.
If you have any further questions on the use of this medicine, ask your healthcare professional.
Overdose:
| If you think you, or a person you are caring for, have taken too much SOGROYA®, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms. |
|---|
Missed Dose:
If you forget to inject a dose:
- and it is 3 days or less after you should have used SOGROYA®, use it as soon as you remember. Then inject your next dose as usual the following week.
- and it is more than 3 days since you should have used SOGROYA®, skip the missed dose. Then inject your next dose as usual on your next scheduled day.
Do not take an extra dose or increase the dose to make up for a missed dose.
Possible side effects from using SOGROYA®:
These are not all the possible side effects you may have when taking SOGROYA®. If you experience any side effects not listed here, tell your healthcare professional.
Side effects seen in children and adolescents
Very common: (may affect more than 1 in 10 people)
- Headache
Common: (may affect up to 1 in 10 people)
- Swollen hands and feet due to fluid retention
- Decreased thyroid hormone (hypothyroidism)
- Redness and pain in the area of injection
- Joint pain
- High blood sugar (hyperglycemia)
- Feeling very tired (fatigue)
- The adrenal glands do not make enough steroid hormones (adrenocortical insufficiency)
Side effects seen in adults
Very common: (may affect more than 1 in 10 people)
- Headache
Common: (may affect up to 1 in 10 people)
- Swollen hands and feet due to fluid retention
- Decreased thyroid hormone (hypothyroidism)
- The adrenal glands do not make enough steroid hormones (adrenocortical insufficiency)
- Feeling very tired or weak (fatigue or asthenia)
- Redness and pain in the area of injection
- High blood sugar (hyperglycemia)
- Joint pain
- Feeling of ‘pins and needles’ mainly in fingers
Uncommon: (may affect up to 1 in 100 people)
- Thickening of skin where you inject your medicine (lipohypertrophy)
- Numb feeling and tingling in your hand(s) (carpal tunnel syndrome)
Serious side effects and what to do about them
| Frequency / Side Effect / Symptom | Talk to your healthcare professional | Stop taking this drug and get immediate medical help | |
|---|---|---|---|
| Only if severe | In all cases | ||
| VERY COMMON | |||
| Headache | ✓ | ||
| COMMON | |||
| Swollen hands and feet due to fluid retention | ✓ | ||
| Decreased thyroid hormone (hypothyroidism) | ✓ | ||
| Redness and pain in the area of injection | ✓ | ||
| Joint pain | ✓ | ||
| High blood sugar (hyperglycemia) | ✓ | ||
| Feeling very tired or weak (fatigue or asthenia) | ✓ | ||
| The adrenal glands do not make enough steroid hormones (adrenocortical insufficiency). | ✓ | ||
| Feeling of ‘pins and needles’ mainly in fingers | ✓ | ||
| RARE | |||
| Thickening of skin where you inject your medicine (lipohypertrophy) | ✓ | ||
| Numb feeling and tingling in your hand(s) (carpal tunnel syndrome) | ✓ | ||
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.
Reporting Side Effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice. |
Storage:
Do not use this medicine after the expiry date which is stated on the pen label and carton after ’EXP’. The expiry date refers to the last day of that month.
Store in a refrigerator (2 °C - 8 °C). Do not freeze. Keep away from the cooling element.
After first opening You can keep the pen for 6 weeks when stored in a refrigerator (2 °C - 8 °C).
Before and after first opening
- Store in a refrigerator (2°C - 8°C).
- Do not use SOGROYA® if it has been frozen.
- Keep SOGROYA® in the carton so that it stays clean and protected from light.
If you are not able to store SOGROYA® in a refrigerator:
- you can keep it at room temperature, 30°C and below for a maximum of 72 hours (3 days). This is as long as you keep SOGROYA® as cool as possible and away from direct heat and light.
- place SOGROYA® back in the refrigerator as soon as possible.
- if you store SOGROYA® out of the refrigerator multiple times and then return to the refrigerator, the total combined time out of the refrigerator is 72 hours (3 days). Monitor this carefully.
- do not use SOGROYA® if it has been stored for more than 72 hours (3 days) at up to 30 °C or for any period above 30 °C.
When you are not using the pen, keep SOGROYA® in the outer carton with pen cap on to protect from light.
Always remove the injection needle after each injection and store the pen without a needle attached.
Do not use this medicine if the solution does not appear clear to slightly opalescent, colourless to slightly yellow and free from visible particles.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Keep out of reach and sight of children.
If you want more information about SOGROYA®:
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website (http://www.novonordisk.ca), or by calling 1-800-465-4334.
Date of Authorization: 2026-05-22
SOGROYA® is a registered trademark owned by Novo Nordisk Health Care AG and used under licence by Novo Nordisk Canada Inc.
NovoFine® is a registered trademark owned by Novo Nordisk A/S and used under licence by Novo Nordisk Canada Inc.
© 2025
Novo Nordisk Canada Inc.
Instructions for Use
Overview of Sogroya® pen Pen cap Pen window Dose counter Dose pointer Dose selector Dose button Sogroya® Pen scale Outer needle cap Inner needle cap Needle Paper tab Needle (example) |
|---|
Important information
To store your pen, see ’Storage’ in the Patient Medication Information. How to use your once weekly SOGROYA® pen 5 steps you should follow for a SOGROYA® injection: Step 1. Prepare your SOGROYA® pen Step 2. Check the flow with each new pen Step 3. Select your dose Step 4. Inject your dose Step 5. After your injection For further information about your pen: see sections Frequently Asked Questions, Important information, Patient Information Please read these instructions carefully before using your SOGROYA® prefilled pen. |
Pay special attention to these notes as they are important for safe use of the pen. Additional information SOGROYA® is a prefilled growth hormone pen. It contains 5 mg of SOGROYA® and delivers doses from 0.025 mg to 2 mg, in increments of 0.025 mg. SOGROYA® is for use under the skin only (subcutaneous). SOGROYA® prefilled pen is designed to be used with NovoFine® disposable needles up to a length of 8 mm. Do not share your SOGROYA® pen and needles with another person. You may give another person an infection or get an infection from them. Do not use your pen without proper training from your doctor or nurse. Make sure that you are confident in making an injection with the pen before you start your treatment. If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the pen. | |
|---|---|
| Step 1. Prepare your once weekly SOGROYA® pen | |
| A ![]() |
| Make sure the right pen is used. Especially if you use more than one type of injectable medicine. Using the wrong medicine could be harmful to your health. | |
| B ![]() |
| C ![]() |
| D ![]() | |
|---|---|---|
Always use a new needle for each injection. This reduces the risk of contamination, infection, leakage of SOGROYA®, and blocked needles leading to incorrect dosing. Never use a bent or damaged needle. | ||
| Step 2. Check the flow with each new pen | ||
If your pen is already in use, proceed to step 3.
| ||
| ||
| Step 3. Select your dose | ||
| ||
| The dose counter shows the dose in mg. See figure H. Always use the dose pointer to select the exact dose. Do not count the pen clicks. Do not use the pen scale. | H Example: 1.825mg selected Example: 1.85 mg selected ![]() |
|---|---|
| If you select the wrong dose, you can turn the dose selector clockwise or counterclockwise to the correct dose. See figure I. The pen clicks sound and feel differently when the dose selector is turned clockwise, counterclockwise, or if you accidentally force it past the number of mg left. | |
| Step 4. Inject your dose | |
| |
| K ![]() |
|---|---|
| |
| Step 5. After your injection | |
| |
| |
| ||
|---|---|---|
| ||
Do not try to put the inner needle cap back on. You may stick yourself with the needle. Always remove the needle from your pen immediately after each injection. This reduces the risk of contamination, infection, leakage of SOGROYA®, and blocked needles leading to incorrect dosing. | ||
| The pen scale shows you approximately how much SOGROYA® is left in your pen. See figure Q. | Q Example: approx. 1 mg left Pen scale ![]() | |
To see how much SOGROYA® is left, use the dose counter: Turn the dose selector clockwise until the dose counter stops. You can select a maximum dose of 2 mg. If it shows “2”, at least 2 mg are left in your pen. If the dose counter stops at “1.2”, only 1.2 mg are left in your pen. See figure R. | R Example: 1.2 mg left ![]() | |
| Frequently Asked Questions | ||
| What if I need a larger dose than what is left in my pen? | It is not possible to select a larger dose than the amount of mg left in your pen. If you need more SOGROYA® than you have left in your pen, you can use a new pen or split your dose between your current pen and a new pen. Only if trained or advised by your doctor or nurse, may you split your dose. Use a calculator to plan the doses as instructed by your doctor or nurse. Be very careful to calculate correctly, otherwise it may lead to medication error. If you are not sure how to split your dose using two pens, then select and inject the dose you need with a new pen. |
|---|---|
| What if no SOGROYA® appears when I check the flow? | A. Your needle may be blocked or damaged, if no SOGROYA® appears at the needle tip. Remove the needle as described in step 5 and repeat steps 1 and 2. B. Your pen may be defective, if SOGROYA® still does not appear after changing the needle. Do not use the pen. |
| What if “0” does not appear after completing my injection? | In this case the needle or pen may be blocked or damaged, and you have not received any SOGROYA® – even though the dose counter has moved from the original dose that you have set. Remove the needle as described in step 5 and repeat steps 1 to 4. |
| How should I take care of my pen? | Be careful not to drop your pen or knock it against hard surfaces. Do not expose your pen to dust, dirt, liquid, or direct light. If there is SOGROYA® left in the pen, store the pen as directed in ’Storage’ in the Patient Medication Information. Do not try to refill your pen, it is prefilled and must be disposed of when empty. |
| What if I drop my pen? | If you drop your pen or think that something is wrong with it, attach a new disposable needle and check the flow before you inject, see steps 1 and 2. If your pen has been dropped, check the cartridge, if the cartridge is cracked, do not use the pen. Do not try to repair your pen or pull it apart. |
| How do I clean my pen? | Do not wash, soak, or lubricate your pen. It may be cleaned with a mild detergent on a moistened cloth. |
| Instructions for Use |
|---|
Overview of Sogroya® pen Pen cap Pen window Dose counter Dose pointer Dose selector Dose button Sogroya® Pen scale Outer needle cap Inner needle cap Needle Paper tab Needle (example) |
Important information
To store your pen, see ’Storage’ in the Patient Medication Information. How to use your once weekly SOGROYA® pen 5 steps you should follow for a SOGROYA® injection: Step 1. Prepare your SOGROYA® pen Step 2. Check the flow with each new pen Step 3. Select your dose Step 4. Inject your dose Step 5. After your injection |
For further information about your pen: see sections Frequently Asked Questions, Important information, Patient Information Please read these instructions carefully before using your SOGROYA® prefilled pen. Pay special attention to these notes as they are important for safe use of the pen. Additional information SOGROYA® is a prefilled growth hormone pen. It contains 10 mg of SOGROYA® and delivers doses from 0.05 mg to 4 mg, in increments of 0.05 mg. SOGROYA® is for use under the skin only (subcutaneous). SOGROYA® prefilled pen is designed to be used with NovoFine® disposable needles up to a length of 8 mm. Do not share your SOGROYA® pen and needles with another person. You may give another person an infection or get an infection from them. Do not use your pen without proper training from your doctor or nurse. Make sure that you are confident in making an injection with the pen before you start your treatment. If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the pen. | |
|---|---|
| Step 1. Prepare your once weekly SOGROYA® pen | |
| A ![]() |
| Make sure the right pen is used. Especially if you use more than one type of injectable medicine. Using the wrong medicine could be harmful to your health. | |
| B ![]() |
| C ![]() | |
|---|---|---|
| D ![]() | |
Always use a new needle for each injection. This reduces the risk of contamination, infection, leakage of SOGROYA®, and blocked needles leading to incorrect dosing. Never use a bent or damaged needle. | ||
| Step 2. Check the flow with each new pen | ||
If your pen is already in use, proceed to step 3.
| ||
| ||
| Step 3. Select your dose | |
|---|---|
| |
| The dose counter shows the dose in mg. See figure H. Always use the dose pointer to select the exact dose. Do not count the pen clicks. Do not use the pen scale. | |
| If you select the wrong dose, you can turn the dose selector clockwise or counterclockwise to the correct dose. See figure I. The pen clicks sound and feel differently when the dose selector is turned clockwise, counterclockwise, or if you accidentally force it past the number of mg left. | |
| Step 4. Inject your dose | |
| |
| |
|---|---|
| |
| Step 5. After your injection | |
| |
| |
| |
|---|---|
| |
Do not try to put the inner needle cap back on. You may stick yourself with the needle. Always remove the needle from your pen immediately after each injection. This reduces the risk of contamination, infection, leakage of SOGROYA®, and blocked needles leading to incorrect dosing. | |
| The pen scale shows you approximately how much SOGROYA® is left in your pen. See figure Q. | |
To see how much SOGROYA® is left, use the dose counter: Turn the dose selector clockwise until the dose counter stops. You can select a maximum dose of 4 mg. If it shows “4”, at least 4 mg are left in your pen. If the dose counter stops at “2.8”, only 2.8 mg are left in your pen. See figure R. |
| Frequently Asked Questions | |
|---|---|
| What if I need a larger dose than what is left in my pen? | It is not possible to select a larger dose than the amount of mg left in your pen. If you need more SOGROYA® than you have left in your pen, you can use a new pen or split your dose between your current pen and a new pen. Only if trained or advised by your doctor or nurse, may you split your dose. Use a calculator to plan the doses as instructed by your doctor or nurse. Be very careful to calculate correctly, otherwise it may lead to medication error. If you are not sure how to split your dose using two pens, then select and inject the dose you need with a new pen. |
| What if no SOGROYA® appears when I check the flow? | A. Your needle may be blocked or damaged, if no SOGROYA® appears at the needle tip. Remove the needle as described in step 5 and repeat steps 1 and 2. B. Your pen may be defective, if SOGROYA® still does not appear after changing the needle. Do not use the pen. |
| What if “0” does not appear after completing my injection? | In this case the needle or pen may be blocked or damaged, and you have not received any SOGROYA® – even though the dose counter has moved from the original dose that you have set. Remove the needle as described in step 5 and repeat steps 1 to 4. |
| How should I take care of my pen? | Be careful not to drop your pen or knock it against hard surfaces. Do not expose your pen to dust, dirt, liquid, or direct light. If there is SOGROYA® left in the pen, store the pen as directed in ’Storage’ in the Patient Medication Information. Do not try to refill your pen, it is prefilled and must be disposed of when empty. |
| What if I drop my pen? | If you drop your pen or think that something is wrong with it, attach a new disposable needle and check the flow before you inject, see steps 1 and 2. If your pen has been dropped, check the cartridge, if the cartridge is cracked, do not use the pen. Do not try to repair your pen or pull it apart. |
| How do I clean my pen? | Do not wash, soak, or lubricate your pen. It may be cleaned with a mild detergent on a moistened cloth. |
| Instructions For Use |
|---|
Overview of Sogroya® Pen Pen cap Pen window Dose counter Dose pointer Dose selector Dose button Sogroya® Pen scale Outer needle cap Inner needle cap Needle Paper tab Needle (example) |
Important information
To store your pen, see ’Storage’ in the Patient Medication Information. How to use your once weekly SOGROYA® pen 5 steps you should follow for a SOGROYA® injection: Step 1. Prepare your SOGROYA® pen Step 2. Check the flow with each new pen Step 3. Select your dose Step 4. Inject your dose |
Step 5. After your injection For further information about your pen: see sections Frequently Asked Questions, Important information, Patient Information Please read these instructions carefully before using your SOGROYA® prefilled pen. Pay special attention to these notes as they are important for safe use of the pen. Additional information SOGROYA® is a prefilled growth hormone pen. It contains 15 mg of SOGROYA® and delivers doses from 0.1 mg to 8 mg, in increments of 0.1 mg. SOGROYA® is for use under the skin only (subcutaneous). SOGROYA® prefilled pen is designed to be used with NovoFine® disposable needles up to a length of 8 mm. Do not share your SOGROYA® pen and needles with another person. You may give another person an infection or get an infection from them. Do not use your pen without proper training from your doctor or nurse. Make sure that you are confident in making an injection with the pen before you start your treatment. If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help. Get help from a person with good eyesight who is trained to use the pen. | |
|---|---|
| Step 1. Prepare your once weekly SOGROYA® pen | |
| A ![]() |
| Make sure the right pen is used. Especially if you use more than one type of injectable medicine. Using the wrong medicine could be harmful to your health. | |
| B ![]() |
| C ![]() | |
|---|---|---|
| D ![]() | |
Always use a new needle for each injection. This reduces the risk of contamination, infection, leakage of SOGROYA®, and blocked needles leading to incorrect dosing. Never use a bent or damaged needle. | ||
| Step 2. Check the flow with each new pen | ||
If your pen is already in use, proceed to step 3.
| ||
| ||
| Step 3. Select your dose | |
|---|---|
| |
| The dose counter shows the dose in mg. See figure H. Always use the dose pointer to select the exact dose. Do not count the pen clicks. Do not use the pen scale. | |
| If you select the wrong dose, you can turn the dose selector clockwise or counterclockwise to the correct dose. See figure I. The pen clicks sound and feel differently when the dose selector is turned clockwise, counterclockwise, or if you accidentally force it past the number of mg left. | |
| Step 4. Inject your dose | |
|---|---|
| |
The “0” must line up with the dose pointer. You may then hear or feel a click. If “0” does not appear in the dose counter after continuously pressing the dose button, your needle or pen may be blocked or damaged, see Frequently Asked Questions. | |
| |
| Step 5. After your injection | |
|---|---|
| |
| |
|---|---|
| |
| |
Do not try to put the inner needle cap back on. You may stick yourself with the needle. Always remove the needle from your pen immediately after each injection. This reduces the risk of contamination, infection, leakage of SOGROYA®, and blocked needles leading to incorrect dosing. |
| The pen scale shows you approximately how much SOGROYA® is left in your pen. See figure Q. |
|---|
To see how much SOGROYA® is left, use the dose counter: Turn the dose selector clockwise until the dose counter stops. You can select a maximum dose of 8 mg. If it shows “8”, at least 8 mg are left in your pen. If the dose counter stops at “4.8”, only 4.8 mg are left in your pen. See figure R. | |
|---|---|
| Frequently Asked Questions | |
| What if I need a larger dose than what is left in my pen? | It is not possible to select a larger dose than the amount of mg left in your pen. If you need more SOGROYA® than you have left in your pen, you can use a new pen or split your dose between your current pen and a new pen. Only if trained or advised by your doctor or nurse, may you split your dose. Use a calculator to plan the doses as instructed by your doctor or nurse. Be very careful to calculate correctly, otherwise it may lead to medication error. If you are not sure how to split your dose using two pens, then select and inject the dose you need with a new pen. |
| What if no SOGROYA® appears when I check the flow? | A. Your needle may be blocked or damaged, if no SOGROYA® appears at the needle tip. Remove the needle as described in step 5 and repeat steps 1 and 2. B. Your pen may be defective, if SOGROYA® still does not appear after changing the needle. Do not use the pen. |
| What if “0” does not appear after completing my injection? | In this case the needle or pen may be blocked or damaged, and you have not received any SOGROYA® – even though the dose counter has moved from the original dose that you have set. Remove the needle as described in step 5 and repeat steps 1 to 4. |
| How should I take care of my pen? | Be careful not to drop your pen or knock it against hard surfaces. Do not expose your pen to dust, dirt, liquid, or direct light. If there is SOGROYA® left in the pen, store the pen as directed in ’Storage’ in the Patient Medication Information. Do not try to refill your pen, it is prefilled and must be disposed of when empty. |
| What if I drop my pen? | If you drop your pen or think that something is wrong with it, attach a new disposable needle and check the flow before you inject, see steps 1 and 2. If your pen has been dropped, check the cartridge, if the cartridge is cracked, do not use the pen. Do not try to repair your pen or pull it apart. |
| How do I clean my pen? | |
| Do not wash, soak, or lubricate your pen. It may be cleaned with a mild detergent on a moistened cloth. |



































































